Literature DB >> 9767566

Identification of a novel gene involved in pilin glycosylation in Neisseria meningitidis.

M P Jennings1, M Virji, D Evans, V Foster, Y N Srikhanta, L Steeghs, P van der Ley, E R Moxon.   

Abstract

The pili of Neisseria meningitidis are a key virulence factor, being major adhesins of this capsulate organism that contribute to specificity for the human host. Recently it has been reported that meningococcal pili are post-translationally modified by the addition of an O-linked trisaccharide, Gal (beta1-4) Gal (alpha1-3) 2,4-diacetimido-2,4,6-trideoxyhexose. Using a set of random genomic sequences from N. meningitidis strain MC58, we have identified a novel gene homologous to a family of glycosyltransferases. A plasmid clone containing the gene was isolated from a genomic library of N. meningitidis strain MC58 and its nucleotide sequence determined. The clone contained a complete copy of the gene, here designated pglA (pilin glycosylation). Insertional mutations were constructed in pglA in a range of meningococcal strains with well-defined lipopolysaccharide (LPS) or pilin-linked glycan structures to determine whether pglA had a role in the biosynthesis of these molecules. There was no alteration in the phenotype of LPS from pglA mutant strains as judged by gel migration and the binding of monoclonal antibodies. In contrast, decreased gel migration of the pilin subunit molecules of pglA mutants was observed, which was similar to the migration of pilins of galE mutants of same strains, supporting the notion that pglA is a glycosyltransferase involved in the biosynthesis of the pilin-linked trisaccharide structure. The pglA mutation, like the galE mutation reported previously, had no effect on pilus-mediated adhesion to human epithelial or endothelial cells. Pilin from pglA mutants were unable to bind to monospecific antisera recognizing the Gal (beta1-4) Gal structure, suggesting that PglA is a glycosyltransferase involved in the addition of galactose of the trisaccharide substituent of pilin.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9767566     DOI: 10.1046/j.1365-2958.1998.00962.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  35 in total

Review 1.  Phase and antigenic variation in bacteria.

Authors:  Marjan W van der Woude; Andreas J Bäumler
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

Review 2.  Protein glycosylation in bacteria: sweeter than ever.

Authors:  Harald Nothaft; Christine M Szymanski
Journal:  Nat Rev Microbiol       Date:  2010-11       Impact factor: 60.633

3.  The phase-variable allele of the pilus glycosylation gene pglA is not strongly associated with strains of Neisseria gonorrhoeae isolated from patients with disseminated gonococcal infection.

Authors:  P M Power; S C Ku; K Rutter; M J Warren; E A Limnios; J W Tapsall; M P Jennings
Journal:  Infect Immun       Date:  2007-02-12       Impact factor: 3.441

Review 4.  Type IV pilin proteins: versatile molecular modules.

Authors:  Carmen L Giltner; Ylan Nguyen; Lori L Burrows
Journal:  Microbiol Mol Biol Rev       Date:  2012-12       Impact factor: 11.056

5.  Genetic, structural, and antigenic analyses of glycan diversity in the O-linked protein glycosylation systems of human Neisseria species.

Authors:  Bente Børud; Finn Erik Aas; Ashild Vik; Hanne C Winther-Larsen; Wolfgang Egge-Jacobsen; Michael Koomey
Journal:  J Bacteriol       Date:  2010-04-02       Impact factor: 3.490

6.  Molecular characterization of the locus encoding biosynthesis of the lipopolysaccharide O antigen of Escherichia coli serotype O113.

Authors:  A W Paton; J C Paton
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

7.  Unique modifications with phosphocholine and phosphoethanolamine define alternate antigenic forms of Neisseria gonorrhoeae type IV pili.

Authors:  Finn Terje Hegge; Paul G Hitchen; Finn Erik Aas; Heidi Kristiansen; Cecilia Løvold; Wolfgang Egge-Jacobsen; Maria Panico; Weng Yee Leong; Victoria Bull; Mumtaz Virji; Howard R Morris; Anne Dell; Michael Koomey
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

8.  Recombinant truncated AniA of pathogenic Neisseria elicits a non-native immune response and functional blocking antibodies.

Authors:  Lucy K Shewell; Shan C Ku; Benjamin L Schulz; Freda E-C Jen; Tsitsi D Mubaiwa; Margaret R Ketterer; Michael A Apicella; Michael P Jennings
Journal:  Biochem Biophys Res Commun       Date:  2013-01-09       Impact factor: 3.575

9.  Alternative Neisseria spp. type IV pilin glycosylation with a glyceramido acetamido trideoxyhexose residue.

Authors:  Julia Chamot-Rooke; Benoit Rousseau; Fanny Lanternier; Guillain Mikaty; Emilie Mairey; Christian Malosse; Guy Bouchoux; Vladimir Pelicic; Luc Camoin; Xavier Nassif; Guillaume Duménil
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-05       Impact factor: 11.205

Review 10.  Mechanisms in Neisseria meningitidis for resistance against complement-mediated killing.

Authors:  Elisabeth Kugelberg; Bridget Gollan; Christoph M Tang
Journal:  Vaccine       Date:  2008-12-30       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.